Literature DB >> 19693530

Optimal treatment of retinal angiomatous proliferation.

Lazaros Konstantinidis, Leonidas Zografos, Irmela Mantel, Aude Ambresin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19693530     DOI： 10.1007/s00417-009-1159-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  2 in total

1.  Intravitreal ranibizumab (Lucentis) in the treatment of retinal angiomatous proliferation (RAP).

Authors:  Lazaros Konstantinidis; Evangelia Mameletzi; Irmela Mantel; Jean-Antoine Pournaras; Leonidas Zografos; Aude Ambresin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-04-29       Impact factor: 3.117

2.  Intravitreal ranibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation: a prospective study.

Authors:  Alexandros A Rouvas; Thanos D Papakostas; Demetrios Vavvas; Ioannis Vergados; Marilita M Moschos; Athanasios Kotsolis; Ioannis D Ladas
Journal:  Retina       Date:  2009-04       Impact factor: 4.256
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.